The impact of stromal cell contamination on chemosensitivity testing of head and neck carcinoma
- PMID: 15015616
The impact of stromal cell contamination on chemosensitivity testing of head and neck carcinoma
Abstract
Background: Reliable chemosensitivity testing of head and neck squamous cell carcinoma (HNSCC) still faces methodical limitations. Since stromal cell contamination has been found to preclude reliable radiosensitivity testing of HNSCC as well as chemosensitivity testing of lung tumors, the present study investigates the impact of stromal cell contamination on chemosensitivity testing of HNSCC.
Patients and methods: Seventeen biopsies from HNSCC were analyzed. The specimens were investigated using an ex vivo colony formation assay which allows for the quantitative and separate determination of the overall, as well as the epithelial, and stromal response to carboplatin, 5-fluorouracil and docetaxel.
Results: The overall chemoresponse was dominated by stromal cell multidrug resistance. However, by selective evaluation of the epithelial chemoresponse, individual chemosensitivity patterns could be identified.
Conclusion: Multidrug-resistant stromal cells preclude the reliable assessment of the chemoresponse of HNSCC specimens. Carefiul correction for stromal cell effects is a prerequisite for the generation of therapeutically useful information.
Similar articles
-
Ex vivo responsiveness of head and neck squamous cell carcinoma to vinorelbine.Anticancer Res. 2006 May-Jun;26(3B):2361-5. Anticancer Res. 2006. PMID: 16821617
-
Ex vivo chemosensitivity of head and neck carcinoma to cytostatic drug combinations.Anticancer Res. 2006 Mar-Apr;26(2B):1651-5. Anticancer Res. 2006. PMID: 16619587
-
Heterogeneity of epithelial and stromal cells of head and neck squamous cell carcinomas in ex vivo chemoresponse.Cancer Chemother Pharmacol. 2010 May;65(6):1153-63. doi: 10.1007/s00280-009-1124-4. Epub 2009 Sep 22. Cancer Chemother Pharmacol. 2010. PMID: 19771432
-
[Ex-vivo-chemoresponse testing of head and neck cancer: an old hat?].Laryngorhinootologie. 2011 Aug;90(8):464-8. doi: 10.1055/s-0031-1283137. Epub 2011 Aug 1. Laryngorhinootologie. 2011. PMID: 21809229 Review. German.
-
Is there a role for chemosensitivity tests in head and neck cancer?Onkologie. 2004 Jun;27(3):310-5. doi: 10.1159/000077984. Onkologie. 2004. PMID: 15249723 Review.
Cited by
-
Assay-based response evaluation in head and neck oncology: requirements for better decision making.Eur Arch Otorhinolaryngol. 2010 Apr;267(4):483-94. doi: 10.1007/s00405-009-1191-5. Epub 2010 Jan 6. Eur Arch Otorhinolaryngol. 2010. PMID: 20052589
-
Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance.Br J Cancer. 2014 Jan 21;110(2):479-88. doi: 10.1038/bjc.2013.700. Epub 2013 Nov 21. Br J Cancer. 2014. PMID: 24263061 Free PMC article.
-
Perspectives in chemosensitivity and chemoresistance assays and their implementation in head and neck cancer.Eur Arch Otorhinolaryngol. 2016 Dec;273(12):4073-4080. doi: 10.1007/s00405-015-3893-1. Epub 2016 Jan 11. Eur Arch Otorhinolaryngol. 2016. PMID: 26755047 Review.
-
[Preclinical models to establish innovative therapy strategies : Ex‑vivo assessment of head and neck tumor chemo- and immune responses].HNO. 2016 Jul;64(7):460-9. doi: 10.1007/s00106-016-0160-8. HNO. 2016. PMID: 27259639 Review. German.
-
Prediction of individual response to anticancer therapy: historical and future perspectives.Cell Mol Life Sci. 2015 Feb;72(4):729-57. doi: 10.1007/s00018-014-1772-3. Epub 2014 Nov 12. Cell Mol Life Sci. 2015. PMID: 25387856 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical